Superficial Venous Thrombosis of Leg, Secondary Prevention
1 clinical trials · Condition
◉ Watch Superficial Venous Thrombosis of Leg, Secondary Prevention
| Record | Firm | Date |
|---|---|---|
| Mesoglycan (Prisma®) Versus Placebo in Secondary Prevention of the Superficial Venous Thrombosis (NCT03428711) | Quovadis Associazione | 2018-03-26 |
Track Superficial Venous Thrombosis of Leg, Secondary Prevention automatically
Every clearance here is in the API, with alerts when new ones post.